HK1249110A1 - 融合分子 - Google Patents

融合分子

Info

Publication number
HK1249110A1
HK1249110A1 HK18107944.2A HK18107944A HK1249110A1 HK 1249110 A1 HK1249110 A1 HK 1249110A1 HK 18107944 A HK18107944 A HK 18107944A HK 1249110 A1 HK1249110 A1 HK 1249110A1
Authority
HK
Hong Kong
Prior art keywords
fusion molecules
fusion
molecules
Prior art date
Application number
HK18107944.2A
Other languages
English (en)
Inventor
Carsten Corvey
Heike Stump
Jochen Kruip
Christian Lange
Ingo Focken
Dorothea Rat
Thomas Stuedemann
Hans-Falk Rasser
Juergen Schaefer
Bernhard Calandra
Astrid Rey
Michael Mourez
Laurent Fraisse
Christine Rothe
Andrea Allersdorfer
Alexander Wiedenmann
Marlon Hinner
Bradley Lunde
Kristian Jensen
Martin Hülsmeyer
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1249110A1 publication Critical patent/HK1249110A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
HK18107944.2A 2015-07-07 2018-06-21 融合分子 HK1249110A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15306106.4A EP3115371A1 (en) 2015-07-07 2015-07-07 Fusion molecules
PCT/EP2016/065899 WO2017005763A1 (en) 2015-07-07 2016-07-06 Fusion molecules

Publications (1)

Publication Number Publication Date
HK1249110A1 true HK1249110A1 (zh) 2018-10-26

Family

ID=53719726

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107944.2A HK1249110A1 (zh) 2015-07-07 2018-06-21 融合分子

Country Status (26)

Country Link
US (2) US10316071B2 (zh)
EP (2) EP3115371A1 (zh)
JP (1) JP2018524003A (zh)
KR (1) KR20180026755A (zh)
CN (1) CN107849106A (zh)
AR (1) AR105257A1 (zh)
AU (1) AU2016289839A1 (zh)
BR (1) BR112018000155A2 (zh)
CA (1) CA2991298A1 (zh)
CL (1) CL2018000015A1 (zh)
CO (1) CO2018001188A2 (zh)
CR (1) CR20180079A (zh)
DO (1) DOP2018000001A (zh)
EA (1) EA201890234A1 (zh)
EC (1) ECSP18008488A (zh)
HK (1) HK1249110A1 (zh)
IL (1) IL256694A (zh)
MA (1) MA42006A1 (zh)
MX (1) MX2018000206A (zh)
PE (1) PE20180490A1 (zh)
PH (1) PH12018500058A1 (zh)
TN (1) TN2017000547A1 (zh)
TW (1) TW201716435A (zh)
UY (1) UY36772A (zh)
WO (1) WO2017005763A1 (zh)
ZA (1) ZA201708754B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41072A1 (fr) 2015-02-18 2018-10-31 Sanofi Sa Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
EP3115371A1 (en) 2015-07-07 2017-01-11 Sanofi Fusion molecules
EP3946417A1 (en) * 2019-03-29 2022-02-09 Pieris Pharmaceuticals GmbH Inhaled administration of lipocalin muteins
CN111848734B (zh) * 2020-06-17 2022-04-05 自然资源部第三海洋研究所 一种具有荧光特性的铁载体pvd、制备方法及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01215289A (ja) 1988-02-22 1989-08-29 Toa Nenryo Kogyo Kk 遺伝子組換えによる正常ヒト血清アルブミンａの製造方法
FR2649991B2 (fr) 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5908621A (en) 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US6620413B1 (en) 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
CA2233725A1 (en) 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes
ATE307597T1 (de) 1998-06-08 2005-11-15 Hoffmann La Roche Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
US6403564B1 (en) 1998-10-16 2002-06-11 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
JP4469456B2 (ja) 2000-04-19 2010-05-26 第一三共株式会社 緑膿菌鉄獲得系阻害物質のスクリーニング法
EP1377306A1 (en) 2001-03-09 2004-01-07 Dyax Corp. Serum albumin binding moieties
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
US7056702B2 (en) 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
EP1814988A2 (en) 2004-11-26 2007-08-08 Pieris AG Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4)
JP2009509535A (ja) 2005-09-27 2009-03-12 アムニクス， インコーポレイテッド タンパク様薬剤およびその使用
EP2313430B1 (en) * 2008-06-24 2018-05-02 Technische Universität München Muteins of hngal and related proteins with affinity for a given target
JP5913120B2 (ja) 2009-12-07 2016-05-11 ピエリス アーゲーＰｉｅｒｉｓ Ａｇ 所定の標的に対して親和性を有するヒトリポカリン２（Ｌｃｎ２、ｈＮＧＡＬ）の突然変異タンパク質
WO2011149962A1 (en) * 2010-05-24 2011-12-01 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
WO2014076321A1 (en) * 2012-11-19 2014-05-22 Pieris Ag Novel specific-binding polypeptides and uses thereof
CN103074303A (zh) * 2012-12-27 2013-05-01 中国人民解放军第三军医大学 产生抗人ngal特异性单克隆抗体的杂交瘤细胞株及其产生的单克隆抗体与应用
MA41072A1 (fr) 2015-02-18 2018-10-31 Sanofi Sa Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
US10273275B2 (en) 2015-05-18 2019-04-30 Pieris Pharmaceuticals Gmbh Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
EP3115371A1 (en) * 2015-07-07 2017-01-11 Sanofi Fusion molecules

Also Published As

Publication number Publication date
ECSP18008488A (es) 2018-04-30
DOP2018000001A (es) 2018-05-15
PE20180490A1 (es) 2018-03-07
PH12018500058A1 (en) 2018-07-09
ZA201708754B (en) 2018-11-28
MA42006A1 (fr) 2018-09-28
CN107849106A (zh) 2018-03-27
CO2018001188A2 (es) 2018-05-10
TN2017000547A1 (en) 2019-04-12
WO2017005763A1 (en) 2017-01-12
CR20180079A (es) 2018-04-24
CA2991298A1 (en) 2017-01-12
MX2018000206A (es) 2018-02-26
US20190382455A1 (en) 2019-12-19
CL2018000015A1 (es) 2018-07-13
EP3115371A1 (en) 2017-01-11
EP3319986A1 (en) 2018-05-16
BR112018000155A2 (pt) 2018-09-11
AU2016289839A1 (en) 2018-03-01
US10947284B2 (en) 2021-03-16
KR20180026755A (ko) 2018-03-13
TW201716435A (zh) 2017-05-16
UY36772A (es) 2017-01-31
EA201890234A1 (ru) 2018-06-29
US20170029477A1 (en) 2017-02-02
IL256694A (en) 2018-03-29
AR105257A1 (es) 2017-09-20
US10316071B2 (en) 2019-06-11
JP2018524003A (ja) 2018-08-30

Similar Documents

Publication Publication Date Title
HK1244019A1 (zh) 融合蛋白
GB201521858D0 (en) Small molecules
GB201615617D0 (en) Small molecules
GB201509413D0 (en) Fusion protein
GB201412659D0 (en) Molecules
GB201412658D0 (en) Molecules
HK1232136A1 (zh) 融合蛋白
TWI563312B (en) Eyeglasses
TWI563311B (en) Eyeglasses
GB201522391D0 (en) Antibody molecules
GB201504691D0 (en) Fusion protein
HK1249110A1 (zh) 融合分子
EP3353791A4 (en) MAGNETIC COMPRESSION SUPPORTED FUSION
HK1257937A1 (zh) 融合蛋白
GB201500702D0 (en) Alignment aid
SG11201606501PA (en) Nanobody-fluorescent protein fusion
GB201502316D0 (en) Bitcon technology
GB201502073D0 (en) HDEG technology
GB201502617D0 (en) Supports
AU201610412S (en) Sunglasses
GB201521944D0 (en) Improved spectacles
GB201518525D0 (en) Spectacles
GB201516257D0 (en) Setouting application
GB201516387D0 (en) Spectacles etc
GB201514291D0 (en) Spectacles